{{Rsnum
|rsid=7249222
|Gene=AXL
|Chromosome=19
|position=41237956
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 1.8 | 98.2
| MEX | 0.0 | 1.8 | 98.2
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}{{Venter SNP
|rsid=7249222
|allele=G
|frequency=1
|uid=1103691147228
|type=homozygous_SNP
|hugo=AXL
|ensembl gene=ENSG00000167601
|ensembl transcript=ENST00000359092
|sift=TOLERATED
|disease=Has transforming potential in patients with chronic myeloproliferative disorder or chronic myelocytic leukemia.
}}

{{GET Evidence
|gene=AXL
|aa_change=Asn266Asp
|aa_change_short=N266D
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7249222
|overall_frequency_n=128
|overall_frequency_d=128
|overall_frequency=1
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=112
|n_articles=0
|n_articles_annotated=0
|nblosum100=-1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}